Ignite Creation Date:
2024-05-06 @ 8:07 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06258174
Status:
COMPLETED
Last Update Posted:
2024-02-14
First Post:
2024-02-06
Brief Title:
A Study of Two Different Formulations of Pirtobrutinib LOXO-305 In Healthy Participants
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-28
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-22
Completion Date Type:
ACTUAL
First Submit Date:
2024-02-06
First Submit QC Date:
February 6 2024
Study First Post Date:
2024-02-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-06
Last Update Post Date:
2024-02-14
Last Update Post Date Type:
ACTUAL